Low‑ Dose Radiotherapy in the Treatment of Plantar Fasciitis

Česká verze

Authors: E. Hajtmanová ¹; I. Kinclová ¹; Ľ. Kostková ¹; Hajtman Andrej ²; M. Péč ³
Authors place of work: Onkologické centrum, Martinská fakultná nemocnica, Martin, Slovenská republika ¹; Súdno‑ lekárske pracovisko Úradu pre dohľad nad zdravotnou starostlivosťou, pobočka Martin, Slovenská republika ²; Ústav lekárskej biológie JLF UK Martin, Slovenská republika ³
Published in the journal: Klin Onkol 2010; 23(2): 104-110
Category: Původní práce

Summary

Backgrounds:
To evaluate the analgesic effect of low‑dose radiotherapy in the treatment of plantar fasciitis and to analyse prognostic factors.

Patients and Methods:
Retrospective analysis was used in the assessment of the analgesic effect after the 1st and 2nd series of low‑dose radiotherapy. The treatment regime of 273 patients included total dose of 4.0 Gy, with fraction dose 1.0 Gy, received 2– 3 times a week. Recommended follow‑up was 3 months. In 323 cases of plantar fasciitis, prognostic factors (age, sex and pain duration before treatment) were evaluated.

Results:
Analgesic effect of total dose of 4.0 Gy was 55.7% after the 1st series and 74.8% after the 2nd series. The results are comparable to published results. Pain duration before treatment shorter than 6 months had a significant effect on the treatment. Age was also a significant prognostic factor, with benefits in the group of patients younger than 50 years.

Conclusion:
Results confirm the advantageous analgesic effect of the dose regime received by our group of 273 patients. Analysis of prognostic factors shows greater benefit of treatment in the acute stage of plantar fasciitis. When treating young patients, however, the possible risks of radiotherapy should be considered compared to other treatment modalities.

Key words:
plantar fasciitis – low‑dose radiotherapy – prognostic factors

Zdroje

1. Mücke R, Micke O, Reichl B et al. Demographic, clinical and treatment related predictors for event‑freee probability following low dose radiotherapy for painful heel spurs – a retrospective multicenter study of 502 patients. Acta Oncol 2007; 46(2): 239– 246.

2. Furey JG. Plantar fasciitis (The painful heel syndrome). J Bone Joint Surg A 1975; 57: 672– 673.

3. Borrosch D, Berning W, Micke O. On the diagnostic Imaging of heel spurs. Benign News 2001; 2(2): 27– 28.

4. Tracy A. Diagnostika bolestí paty u dospelých. Medicína po promoci 2004; 5(6): 19– 23. Dostupné z: https:/ / www.zdravcentra.sk/ cps/ rde/ xbcr/ zcsk/ 6– 2004_04_SI.pdf.

5. Miszczyk L, Jochymek B, Wozniak G. Retrospective evaluation of radioherapy in plantar fasciitis. Brit J Radiol 2007; 80: 829– 834.

6. Lemont H, Ammirati KM, Usen N. Plantar fasciitis a degenerative (fasciosis) without inflammation. J Am Podiatr Med Assoc 2003; 93(3): 234– 237.

7. Brown C. A review of subcalcaneal heel pain and plantar fasciitis. Aust Fam Physician 1996; 25(6): 875– 881.

8. Niewald M, Seegenschmiedt MH, Micke O et al. Randomized multicenter trial on the effect of radiotherapy for plantar fasciitis (painful heel spur) using very low doses – a study protocol. Phys Oncol 2008; 3: 27– 32.

9. Smith S, Tinley S, Gilheany M et al. The inferior calcaneal spur – anatomical and histological considerations. The Foot 2007; 17(1): 25– 31.

10. Bartold SJ. The plantar fascia as source of pain – biomechanics, presentation and treatment. J BodyWork Mov Ther 2004; 8(3): 214– 226.

11. Micke O, Seegenschmiedt MH. German Cooperative Group on Radiotherapy for Benign Diseases. Radiotherapy in painful heel spurs (plantar fasciitis)– results of a national patterns of care study. Int J Radiat Oncol Biol Phys 2004; 58(3): 828– 843.

12. Schäfer U, Micke O, Glashorsters M et al. The radiotherapy treatment of painful calcaneal spurs. Strahlenther Oncol 1995; 171(4): 202– 206.

13. Národní radiologické standardy – radiační onkologie/ radioterapie. Návrh k 6. 11. 2007: 59– 60. Dostupné z: http:/ / www.srobf.cz/ dokumenty/ standard_RT_11_2007.doc.

14. Šlampa P a kol. Radiační onkologie v praxi. 2. vyd. Brno: Masarykův onkologický ústav 2007: 238– 242.

15. Kvech J, Růžičková J, Šlampa P et al. Nenádorová rádioterapie. In: Šlampa P, Petera J et al. Radiační onkologie. Praha: Galén 2007: 391– 396.

16. Leer JW, van Houtte P, Davelaar J. Indications and treatment schedules for irradiation of benign diseases, a survey. Radiother Oncol 1998; 48(3): 249– 257.

17. Seegenschmiedt MH, Katalinic A, Makoski HB et al. Radiotherapy of benign diseases: a pattern of care study in Germany. Strahlenther Oncol 1999; 175: 541– 547.

18. Micke O, Seegenschmiedt MH. German Working Group on Radiotherapy of Benign Diseases. Consensus guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. Int J Radiat Oncol Biol Phys 2002; 52(2): 496– 513.

19. Cook DL, Guyatt GH, Laupacis A et al. Rules of evidence and clinical recommendations on the use of antithrombotic agens. Chest 1989; 102 (Suppl 2): 305S– 311S.

20. Sackett DL. Rules of evidence and clinical recommendations on the use of anti‑thrombotic agens. Chest 1989; 102 (Suppl 2): 2S– 4S.

21. Leer J, van Houtte P, Seegenschmiedt MH. Radiotherapy of non‑malignant disorders: Where do we stand? Radiother Oncol 2007; 83(2): 175– 177.

22. Miszczyk L, Wozniak G, Jochymek B et al. Evaluation of the effectiveness of the calcaneal spurs radiotherapy. Chir Narzadow Ruchu Ortop Pol 2003; 68(3): 191– 195.

23. Schlöckner I, Lilienthal A, Oehler W. Painful calcaneal spur: is there any influence of radiation quality (ortovoltage vs. high voltage) on pain relief after radiotherapy? Radiother Oncol 2004; 73 (Suppl 1): S233– S234.

24. Seegenschmiedt MH, Keilholz L, Katalinic A et al. Heel spur: radiation therapy for refractory pain – results with three treatment concepts. Radiology 1996; 200: 271– 276.

25. Arenas M, Gil F, Gironella M et al. Time course of anti‑inflammatory effect of low‑dose radiotherapy: Correlation with TGF‑b1 expression. Radiother Oncol 2008; 86(3): 399– 406.

26. Schneider O, Stückle CA, Bosch E et al. Effectiveness and prognostic factors of radiotherapy for painful plantar heel spurs. Benign News 2002; 3(1): 3– 5.

27. Calcaneodynia – Score of the GCG- BP. Benign News 2001; 2(2): 23– 24.

28. Schneider O, Stückle CA, Bosch E et al. Effectiveness and prognostic factors of radiotherapy for painful plantar heel spurs. Benign News 2002; 3(1): 3– 5.

29. Mücke R, Schönekaes K, Micke O et al. Low‑dose radiotherapy for painful heel spur. Retrospective study of 117 patients. Strahlenther Oncol 2003; 179(11): 774– 778.

30. Rödel F, Hofmann D, Auer J et al. The anti‑inflammatory effect of low‑dose radiation therapy involves a dimnished CCL20 chemokine expression and granulocyte/ endotelial cell adhesion. Strahlenther Oncol 2008; 184(1): 41– 47.

31. Surenkok S, Dirican B, Beyzadeoglu M et al. Heel spur radiotherapy and radiation carcinogenesis risk estimation. Radiat Med 2006; 24(8): 573– 576.

32. Broerse JJ, Jansen JTM, Seegenschmiedt MH. Carcinogenic risks in radiotherapy of benign diseases from head to heel. Radiother Oncol 2004; 71 (Suppl 1): 1S.

33. Trott KR. Can we reduce the incidence of second primary malignancies occuring after radiotherapy? Radiother Oncol 2009; 91(1): 1– 3.

34. Tubiana M. Can we reduce the incidence of second primary malignancies after radio therapy? A critical review. Radiother Oncol 2009; 91(1): 4– 15.